drugset / Trial / NCT01901887

The Better Resiliency Among Veterans With Omega-3's (BRAVO) Study

NCT01901887 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The BRAVO study seeks to determine if dietary supplementation with omega-3 highly unsaturated fatty acids (omega-3 HUFAs) reduces the risk for serious suicidal behaviors, suicidal thinking, negative emotions, and symptoms associated with suicide risk, in a Veteran and non-Veteran population that is at risk for suicidal behaviors. This study seeks to evaluate the efficacy of omega-3 HUFAs among a representative population of US Veterans and non-Veterans already receiving appropriate medical care so that if successful, these results can be readily applied to broader populations in the US.

Timeline

Start
2014-03-01
Primary completion
2016-08-30
Completion
2016-08-30

Outcome

Outcome not reported

Stopped (Enrollment): “low recruitment”

Drugs

EvaluationDrugModalityDoseRoute
Subject omega-3 HUFAs Unknown 3300 mg —

Indications

No indication recorded.